Sponsor or institution

Clinical trials and research at Instituto de Investigación Biomédica de Salamanca

• 13Clinical trials
• 3Countries

Newest trials

All recruiting trials (13)

• Personalized exercise prescription for adults 65 and older

  This project will try a personalized exercise prescription delivered in primary care to see if it helps sedentary adults aged 65 and older improve fitness, muscle strength, and quality of life.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Villoría, Salamanca · NCT07394790

• Urinary biomarker test and real-world use of SGLT2 inhibitors in CKD

  This study tests whether SGLT2 inhibitors used in routine care help slow kidney function decline in adults with CKD and whether a urinary biomarker panel can detect and monitor progression.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Salamanca · NCT07348484

• Four-year follow-up to find predictors of long COVID progression

  This follow-up will try to see if changes in blood proteins and blood vessel tests can predict how long COVID symptoms, especially persistent fatigue, change over four years in people who had long COVID.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Salamanca, Salamanca · NCT07295483

• Plasma Host-Microbe Proteomics to Predict Complications in High-Risk Febrile Neutropenia

  Researchers will test a combined host and microbial blood proteome to see if it can predict which high-risk febrile neutropenia patients will develop complications.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Barcelona, Barcelona and 2 other locations · NCT07277387

• Using Advanced CT Scans and Blood Markers to Understand Heart Damage and Recovery After a Heart Attack

  Doctors are testing a combination of spectral CT imaging and blood biomarkers to see if they can better understand and predict how the heart heals after a heart attack in adults who recently had STEMI treated with PCI.

  Recruiting at 4 sites Instituto de Investigación Biomédica de Salamanca · Madrid and 3 other locations · NCT07268391

• Fluorescent bile duct imaging with standard versus reduced indocyanine green doses during laparoscopic gallbladder removal

  This will see if a much lower dose of indocyanine green given shortly before laparoscopic gallbladder removal shows the bile ducts as well as the standard higher dose given hours earlier.

  Recruiting Phase 4 Instituto de Investigación Biomédica de Salamanca · Salamanca, Salamanca and 1 other locations · NCT07195331

• Next‑generation immune profiling to find response and toxicity markers in skin cancer patients treated with cemiplimab

  This project will test whether advanced blood and tumor immune profiling can help predict who with advanced cutaneous squamous cell carcinoma will benefit from cemiplimab and who may develop side effects.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Salamanca, Salamanca · NCT07064330

• Higher-dose twice-daily chest radiotherapy for limited-stage small cell lung cancer

  This trial will test if higher-dose, twice-daily chest radiotherapy given with standard cisplatin and etoposide helps people with limited-stage small cell lung cancer live longer and delay recurrence.

  Recruiting at 3 sites Phase 3 Instituto de Investigación Biomédica de Salamanca · Salamanca, Salamanca and 12 other locations · NCT07015892

• Software that analyzes heart CT scans to detect coronary artery disease

  This project will test a new software that uses past coronary CT scans to see if it can accurately find blockages and predict which patients might need procedures.

  Recruiting at 4 sites Instituto de Investigación Biomédica de Salamanca · Villeurbanne and 3 other locations · NCT06977295

• Examining the role of inflammation in blood cell deficiencies after CAR-T therapy

  This study is trying to see how inflammation affects blood cell problems in patients with diffuse large B-cell lymphoma after they receive CAR-T therapy.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Salamanca · NCT06439173

• Improving detection of tumor cells in cutaneous T-cell lymphoma

  This study is testing a new way to find and count tumor cells in the blood of patients with cutaneous T-cell lymphoma to help improve diagnosis and treatment monitoring.

  Recruiting Instituto de Investigación Biomédica de Salamanca · Salamanca · NCT06382844

• Improving diagnosis and treatment of Myelodysplastic Syndromes in Spain

  This study is trying to improve how doctors diagnose and treat Myelodysplastic Syndromes in Spain by using new techniques to find genetic changes in patients.

  Recruiting at 4 sites Instituto de Investigación Biomédica de Salamanca · Badalona, Barcelona and 3 other locations · NCT06379945

• Treatment for relapsed or refractory B-cell lymphoma using CAR T-cell therapy

  This study is testing a new CAR T-cell therapy called TranspoCART19 to see if it can help people with relapsed or refractory B-cell lymphoma feel better.

  Recruiting at 7 sites Phase 1/2 Instituto de Investigación Biomédica de Salamanca · Barcelona, Barcelona and 7 other locations · NCT06378190

Quick answers

How many clinical trials run by Instituto de Investigación Biomédica de Salamanca are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Spain (13 trials), France (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →